Amundi Cellebrite Di Ltd. Transaction History
Amundi
- $253 Billion
- Q2 2024
A detailed history of Amundi transactions in Cellebrite Di Ltd. stock. As of the latest transaction made, Amundi holds 9,423 shares of CLBT stock, worth $158,777. This represents 0.0% of its overall portfolio holdings.
Number of Shares
9,423Holding current value
$158,777% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding CLBT
# of Institutions
155Shares Held
102MCall Options Held
67.8KPut Options Held
30.9K-
Igp Investments (G.P.L.P), LP Herzliya, L321.1MShares$355 Million95.53% of portfolio
-
True Wind Capital Management, L.P.13.4MShares$226 Million79.17% of portfolio
-
Clal Insurance Enterprises Holdings LTD Tel Aviv, L37.65MShares$129 Million0.96% of portfolio
-
Morgan Stanley New York, NY6.99MShares$118 Million0.01% of portfolio
-
Nine Ten Capital Management LLC Evanston, IL3.92MShares$66.1 Million18.05% of portfolio
About Cellebrite DI Ltd.
- Ticker CLBT
- Exchange NASDAQ
- Sector Technology
- Industry Software—Infrastructure
- Shares Outstandng 189,648,992
- Market Cap $3.2B
- Description
- Cellebrite DI Ltd. develops solutions for legally sanctioned investigations. Its DI platform allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations and solutions are used in a various case, including child exploitation, homicide, anti-terror, border c...